APA (7th ed.) Citation

Wu, P., Lin, C., Kuo, C., Chen, W., Yeh, D., Liao, H., . . . Lu, Y. (2015). A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis. BMC Cancer, 15(1), 1. https://doi.org/10.1186/s12885-015-1290-1

Chicago Style (17th ed.) Citation

Wu, Pei-Fang, Ching-Hung Lin, Ching-Hua Kuo, Wei-Wu Chen, Dah-Cherng Yeh, Hsiao-Wei Liao, Shu-Min Huang, Ann-Lii Cheng, and Yen-Shen Lu. "A Pilot Study of Bevacizumab Combined with Etoposide and Cisplatin in Breast Cancer Patients with Leptomeningeal Carcinomatosis." BMC Cancer 15, no. 1 (2015): 1. https://doi.org/10.1186/s12885-015-1290-1.

MLA (9th ed.) Citation

Wu, Pei-Fang, et al. "A Pilot Study of Bevacizumab Combined with Etoposide and Cisplatin in Breast Cancer Patients with Leptomeningeal Carcinomatosis." BMC Cancer, vol. 15, no. 1, 2015, p. 1, https://doi.org/10.1186/s12885-015-1290-1.